Khaled Musallam/LinkedIn
Sep 28, 2025, 08:41
Khaled Musallam Explores Molecular Understanding of β-Thalassemia at The 2nd Abu Dhabi Hematology Annual Review
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared on LinkedIn:
”Great program and talks during the 2nd Abu Dhabi Hematology Annual Review.
Thanks Dr Kayane Mheidly and Sheikh Shakhbout Medical City – SSMC for giving the stage to thalassemia.”
Stay updated with Hemostasis Today.
-
Sep 1, 2026, 02:41Richard Buka: Win a Trip to ASH or ISTH 2027
-
Sep 1, 2026, 02:38Christian’s Journey to Stability on Avatrombopag – ITP Support Association
-
Sep 1, 2026, 02:35Alexis Guédon: Is IL-6 Pathway Inhibition Reduce Cardiovascular Risk in Giant Cell Arteritis?
-
Aug 31, 2026, 17:11Chokri Ben Lamine: Early Recognition and Immediate Treatment of Catastrophic APS
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
-
Aug 31, 2026, 16:47Improving Outcomes in AF-Related Stroke Beyond Anticoagulation at ESC 2026 – ESO
-
Aug 31, 2026, 16:39Shariq Shamim: Are We Going to Start DOAC post TAVI not DAPT?